Article

SUMO pathway dependent recruitment of cellular repressors to herpes simplex virus type 1 genomes.

MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
PLoS Pathogens (impact factor: 9.13). 07/2011; 7(7):e1002123. DOI:10.1371/journal.ppat.1002123 pp.e1002123
Source: PubMed

ABSTRACT Components of promyelocytic leukaemia (PML) nuclear bodies (ND10) are recruited to sites associated with herpes simplex virus type 1 (HSV-1) genomes soon after they enter the nucleus. This cellular response is linked to intrinsic antiviral resistance and is counteracted by viral regulatory protein ICP0. We report that the SUMO interaction motifs of PML, Sp100 and hDaxx are required for recruitment of these repressive proteins to HSV-1 induced foci, which also contain SUMO conjugates and PIAS2β, a SUMO E3 ligase. SUMO modification of PML and elements of its tripartite motif (TRIM) are also required for recruitment in cells lacking endogenous PML. Mutants of PML isoform I and hDaxx that are not recruited to virus induced foci are unable to reproduce the repression of ICP0 null mutant HSV-1 infection mediated by their wild type counterparts. We conclude that recruitment of ND10 components to sites associated with HSV-1 genomes reflects a cellular defence against invading pathogen DNA that is regulated through the SUMO modification pathway.

0 0
 · 
0 Bookmarks
 · 
69 Views
  • Article: Promyelocytic leukemia-nuclear body proteins: herpesvirus enemies, accomplices, or both?
    [show abstract] [hide abstract]
    ABSTRACT: The promyelocytic leukemia (PML) protein gathers other cellular proteins, such as Daxx and Sp100, to form subnuclear structures termed PML-nuclear bodies (PML-NBs) or ND10 domains. Many infecting viral genomes localize to PML-NBs, leading to speculation that these structures may represent the most efficient subnuclear location for viral replication. Conversely, many viral proteins modify or disrupt PML-NBs, suggesting that viral replication may be more efficient in the absence of these structures. Thus, a debate remains as to whether PML-NBs inhibit or enhance viral replication. Here we review and discuss recent data indicating that for herpesviruses, PML-NB proteins inhibit viral replication in cell types where productive, lytic replication occurs, while at the same time may enhance the establishment of lifelong latent infections in other cell types.
    Future Virology 05/2008; 3(3):265-277. · 1.21 Impact Factor
  • Article: New insights into the role of the subnuclear structure ND10 for viral infection
    [show abstract] [hide abstract]
    ABSTRACT: Nuclear domains 10 (ND10), alternatively termed PML nuclear bodies (PML-NBs) or PML oncogenic domains (PODs), have been discovered approximately 15 years ago as a nuclear substructure that is targeted by a variety of viruses belonging to different viral families. This review will summarize the most important structural and functional characteristics of ND10 and its major protein constituents followed by a discussion of the current view regarding the role of this subnuclear structure for various DNA and RNA viruses with an emphasis on herpesviruses. It is concluded that accumulating evidence argues for an involvement of ND10 in host antiviral defenses either via mediating an intrinsic immune response against specific viruses or via acting as a component of the cellular interferon pathway.
    Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.
  • Article: PML and PML nuclear bodies: implications in antiviral defence.
    [show abstract] [hide abstract]
    ABSTRACT: The establishment of an intracellular antiviral state is the defining activity of interferons (IFNs) as well as the property that permitted their discovery. Several pathways have been implicated in resistance to viral infection in IFN-treated cells, one of which implicates the ProMyelocytic Leukaemia (PML) protein and PML nuclear bodies (NBs, also known as ND10). PML NBs are dynamic intranuclear structures that require PML for their formation and which harbour numerous other transiently or permanently localised proteins. PML is expressed as a family of isoforms (PML I-VII) as a result of alternative splicing, most of which are found in the nucleus. IFN treatment directly induces transcription of the genes encoding both PML and Sp100, (another major component of PML NBs), resulting in higher levels of expression of these proteins and increases in both the size and number of PML NBs. These and other observations have encouraged the hypothesis that PML, PML NBs and a number of other constituents of these structures are involved in host antiviral defences. For example, exogenous expression of PML III or PML VI can impede infection by a number of RNA and DNA viruses, and certain viral proteins accumulate in PML NBs then cause their disruption by a variety of mechanisms. Although there are many other functions of PML NBs in a wide range of cellular pathways, there is accumulating evidence that they represent preferential targets for viral infections and that PML plays a role in the mechanism of the antiviral action of IFN. This article reviews the potential antiviral activities of PML NB constituent proteins, how RNA and DNA viruses overcome these defences, and the connections between these events and IFN pathways.
    Biochimie 89(6-7):819-30. · 3.02 Impact Factor

Full-text

View
0 Downloads
Available from

Keywords

cellular response
 
Components
 
herpes simplex virus type 1
 
HSV-1 genomes
 
HSV-1 induced foci
 
ICP0 null mutant HSV-1 infection
 
intrinsic antiviral resistance
 
Mutants
 
ND10 components
 
PIAS2β
 
PML isoform
 
reproduce
 
SUMO E3 ligase
 
SUMO interaction motifs
 
SUMO modification pathway
 
TRIM
 
tripartite motif
 
viral regulatory protein ICP0
 
virus induced foci
 
wild type counterparts